Quick Takeaways
- Nantahala Capital Partners Limited Partnership filed SCHEDULE 13G for KIORA PHARMACEUTICALS, INC. Common Stock, $0.01 par value (KPRX).
- Disclosed ownership: 5.3%.
- Date of event: 08 Aug 2025.
Nantahala Capital Partners Limited Partnership - 08 Aug 2025 SCHEDULE 13G Report for KIORA PHARMACEUTICALS, INC. Common Stock, $0.01 par value (KPRX)
- Filing Manager
- Nantahala Capital Partners Limited Partnership
- Reporting Manager
- NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP
- Symbol
- KPRX
- Shares outstanding
- 3,580,015 shares
- Disclosed Ownership
- 189,705 shares
- Ownership
- 5.3%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Aug 2025, 16:36:24 UTC
- Date of event
- 08 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Nantahala Capital Partners Limited Partnership disclosed 5.3% ownership in KIORA PHARMACEUTICALS, INC. Common Stock, $0.01 par value (KPRX) on 08 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 16:36.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 5.3% | 189,705 | 0 | 189,705 | /s/ Taki Vasilakis | Taki Vasilakis / Chief Compliance Officer Nantahala Capital Management, LLC |